Prostate-specific antigen velocity "adds little value" in detecting prostate cancer
This article was originally published in Clinica
Executive Summary
Adding prostate-specific antigen (PSA) velocity measurements to standard PSA screening for prostate cancer "adds very little predictive value", a study has concluded.